M&A Deal Summary

Johnson & Johnson Acquires Synthes

On April 27, 2011, Johnson & Johnson acquired medical products company Synthes for 19.3B USD

Acquisition Highlights
  • This is Johnson & Johnson’s 13th transaction in the Medical Products sector.
  • This is Johnson & Johnson’s 2nd largest (disclosed) transaction.
  • This is Johnson & Johnson’s 20th transaction in the United States.
  • This is Johnson & Johnson’s 3rd transaction in Pennsylvania.

M&A Deal Summary
Date 2011-04-27
Target Synthes
Sector Medical Products
Buyer(s) Johnson & Johnson
Deal Type Merger
Deal Value 19.3B USD

Target

Synthes

West Chester, Pennsylvania, United States
Synthes a medical device company, specialized in the development, manufacturing and marketing of instruments, implants and biomaterials for the surgical fixation, correction and regeneration of the human skeleton and its soft tissues.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Johnson & Johnson

New Brunswick, New Jersey, United States
Category Company
Founded 1886
Sector Consumer Products
Employees132,000
Revenue 85.2B USD (2023)
DESCRIPTION
Johnson & Johnson's corporate headquarters in New Brunswick, New Jersey.
Johnson & Johnson's corporate headquarters in New Brunswick, New Jersey.

Johnson & Johnson is a global healthcare conglomerate that operates across three primary sectors: Pharmaceuticals, Medical Devices, and Consumer Health. In Pharmaceuticals, it develops treatments for a variety of conditions, including immunology, oncology, and infectious diseases. The Medical Devices segment offers a range of equipment and devices for healthcare professionals, encompassing orthopedics, surgery, and cardiovascular care. Its Consumer Health division markets a wide array of products, spanning baby care, oral care, skin care, over-the-counter drugs, and women's health, with popular brands such as Band-Aid, Tylenol, and Neutrogena under its umbrella. Johnson & Johnson was formed in 1886 and is based in New Brunswick, New Jersey.

DEAL STATS #
Overall 24 of 45
Sector (Medical Products) 13 of 17
Type (Merger) 3 of 3
State (Pennsylvania) 3 of 4
Country (United States) 20 of 37
Year (2011) 1 of 1
Size (of disclosed) 2 of 29
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-10-09 PURELL

Akron, Ohio, United States

PURELL is an instant hand sanitizer for use in foodservice and healthcare situations when people lack access to soap and water. PURELL was introduced to the consumer market in 1997.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-05-11 OraPharma

Horsham, Pennsylvania, United States

OraPharma, Inc. is a pharmaceutical company that discovers, develops and commercializes therapeutics for the treatment of periodontal disease at various phases of progression.

Sell -
Mergr

Product

Company

Legal